The Efficacy and Safety of a Promising Single-Channel Endoscopic Closure Technique for Endoscopic Treatment-Related Artificial Ulcers: A Pilot Study [0.03%]
内镜治疗后人工溃疡的新型单通道内镜闭合技术疗效及安全性的可行性研究：一项前瞻性试点研究
Yosuke Minoda,Eikichi Ihara,Haruei Ogino et al.
Yosuke Minoda et al.
Background/aims: It is important to appropriately manage patients with procedure-related artificial mucosal ulcers or procedure-related complications. Many endoscopic closure techniques have been reported; however, they o...
Aberrant Expression of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer and Their Association with Cancer Progression and Prognosis [0.03%]
过氧化物酶体增殖激活受体在结直肠癌的异常表达及其与肿瘤进展和预后的关系
Musa Yaghoubizadeh,Leila Pishkar,Gholam Basati
Musa Yaghoubizadeh
Introduction: Peroxisome proliferator-activated receptors (PPARs), PPARα, PPARγ, and PPARδ, are nuclear ligand-activated transcription factors which presumably contribute to a broad range of pathophysiological processe...
Cost Analysis of Biliary Drainage Using Metal versus Plastic Stents in Hepatocellular Carcinoma Patients with Obstructive Jaundice [0.03%]
肝癌患者阻塞性黄疸下金属支架与塑料支架胆道引流的费用分析
Esam Elshimi,Wesam Morad
Esam Elshimi
Background: The optimal method of biliary drainage for biliary obstruction caused by hepatocellular carcinoma (HCC) is controversial, and the possible endoscopic application of plastic and metal stents is the least invasi...
"Homomorphic" Tumor Metastases as an Endodiagnostic Clue: A Case Series of Renal-Cell Carcinoma Metastatic to the Stomach [0.03%]
“同形”肿瘤转移作为内源性诊断线索：肾细胞癌转移到胃的病例系列分析
Simcha Weissman,Tej I Mehta,Alex Zhornitskiy et al.
Simcha Weissman et al.
Distinguishing between a primary malignancy and a metastasis can be challenging in some cases. Herein, we describe 2 cases of gastric lesions that were endoscopically sampled and ultimately found to be metastatic from a renal-cell carcinoma...
An Unlikely Route: Metastatic Ovarian Malignancy within the Duodenum [0.03%]
出人意料的途径：十二指肠内的卵巢恶性肿瘤转移灶
Sindhura Kolli,Simcha Weissman,Saad Saleem et al.
Sindhura Kolli et al.
The small bowel is an uncommon site for cancer metastasis. Despite this, cases have reported the duodenum as a metastatic site from local organs. However, duodenal involvement from more distant organs, such as the ovaries, has rarely been r...
Waseem M Seleem,Amr Shaaban Hanafy
Waseem M Seleem
Portal hypertensive polyposis is a rare finding represented in about 2.5% of all patients with portal hypertension. The diagnostic criteria are not yet clearly defined. It has been mentioned in a few case reports; its distribution was mainl...
Wide Sexual Dimorphism of Hepatocellular Carcinoma Presentation in Algeria [0.03%]
阿尔及利亚肝细胞癌的广泛性别二态性表现形式
Yazid Chikhi,Salima Cheraitia,Rachid Ould Gougam et al.
Yazid Chikhi et al.
Hepatocellular carcinoma (HCC) represents a worrying public health problem in North Africa and particularly in Egypt. The situation is unclear in western North Africa where HCC has been rarely submitted to careful scrutiny. We decided to an...
Huge Gastrointestinal Stromal Tumor of the Jejunum Presenting as Bowel Obstruction: A Rare Presentation [0.03%]
罕见的肠道梗阻：巨大的空肠间质瘤病例报告
Tanweerul Huda,Mahendra Pratap Singh
Tanweerul Huda
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointestinal tract arising from interstitial Cajal cells. A 54-year-old male patient without any comorbidities presented to the emergency department with complaints o...
Perioperative Management of Pancreaticoduodenectomy: Avoiding Admission to the Intensive Care Unit [0.03%]
胰十二指肠切除术的围手术期管理：避免入住重症监护病房
Walid Faraj,Deborah Mukherji,Ahmad M Zaghal et al.
Walid Faraj et al.
Introduction: With the advancement in surgical expertise at high-volume centers and advances in perioperative management, pancreaticoduodenectomy is becoming safer and remains the gold standard for treating periampullary ...
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience [0.03%]
基线特征对索拉非尼治疗肝癌患者总生存期的影响：十年回顾
Giulia Rovesti,Giulia Orsi,Andrikou Kalliopi et al.
Giulia Rovesti et al.
Background: Sorafenib has been established as the standard of care for patients with advanced hepatocellular carcinoma (HCC) since 2007 on the basis of two landmark trials (SHARP and Asia-Pacific). Ten years have passed s...